当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析 - 现金流量表

易瑞生物

(300942)

  

流通市值:25.52亿  总市值:25.52亿
流通股本:4.05亿   总股本:4.05亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金165,248,017.2278,030,546.98288,107,810.78190,874,391.53
  收到的税费返还--14,381.914,381.9
  收到其他与经营活动有关的现金8,057,914.633,169,030.1655,930,576.0115,396,217.78
  经营活动现金流入小计173,305,931.8581,199,577.14344,052,768.69206,284,991.21
  购买商品、接受劳务支付的现金79,796,442.0145,638,455.27126,468,276.3672,274,492.2
  支付给职工以及为职工支付的现金58,394,395.1730,760,409.6793,427,919.8870,386,233.92
  支付的各项税费5,451,883.31,385,421.916,364,879.762,384,748.32
  支付其他与经营活动有关的现金35,534,958.915,942,736.950,919,878.8553,410,540.41
  经营活动现金流出小计179,177,679.3893,727,023.75277,180,954.85198,456,014.85
  经营活动产生的现金流量净额-5,871,747.53-12,527,446.6166,871,813.847,828,976.36
二、投资活动产生的现金流量:
  收回投资收到的现金12,590,898.3812,590,898.3820,598,934.4820,598,934.48
  取得投资收益收到的现金1,847,307.621,231,761.635,175,260.224,976,290.47
  处置固定资产、无形资产和其他长期资产收回的现金净额494,30070,00029,177,317.5629,329,300.38
  处置子公司及其他营业单位收到的现金净额--359,143.42359,143.42
  收到的其他与投资活动有关的现金377,162,374.1696,740,505.48810,694,720.8686,213,774.35
  投资活动现金流入小计392,094,880.16110,633,165.49866,005,376.48741,477,443.1
  购建固定资产、无形资产和其他长期资产支付的现金35,701,536.5133,927,808.3645,899,685.4932,164,358.98
  投资支付的现金-017,000,0009,750,000
  支付其他与投资活动有关的现金318,459,279.8648,386,590.73764,596,157.31544,571,355.76
  投资活动现金流出小计354,160,816.3782,314,399.09827,495,842.8586,485,714.74
  投资活动产生的现金流量净额37,934,063.7928,318,766.438,509,533.68154,991,728.36
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,095,0003,005,000640,000240,000
  其中:子公司吸收少数股东投资收到的现金3,095,0003,005,000640,000240,000
  取得借款收到的现金21,765,781.2821,765,781.2826,688,827.6226,688,827.62
  收到其他与筹资活动有关的现金--0-
  筹资活动现金流入小计24,860,781.2824,770,781.2827,328,827.6226,928,827.62
  偿还债务支付的现金16,434,546.7813,217,227.0940,988,926.8438,541,695.13
  分配股利、利润或偿付利息支付的现金13,228,792.441,904,705.3913,857,304.212,552,852.99
  其中:子公司支付给少数股东的股利、利润578,704.58---
  支付其他与筹资活动有关的现金--0-
  筹资活动现金流出小计29,663,339.2215,121,932.4854,846,231.0451,094,548.12
  筹资活动产生的现金流量净额-4,802,557.949,648,848.8-27,517,403.42-24,165,720.5
四、汇率变动对现金及现金等价物的影响-11,223,441.47-6,680,492.72986,297.223,204,826.71
五、现金及现金等价物净增加额16,036,316.8518,759,675.8778,850,241.32141,859,810.93
  加:期初现金及现金等价物余额335,982,200.74335,982,200.74257,131,959.42257,131,959.42
  期末现金及现金等价物余额352,018,517.59354,741,876.61335,982,200.74398,991,770.35
补充资料:
  净利润-19,396,770.83-15,466,356.76-
  资产减值准备2,697,222.96-10,343,338.84-
  固定资产和投资性房地产折旧16,999,448.48-27,937,033.57-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧16,999,448.48-27,937,033.57-
  无形资产摊销973,065.78-1,941,548.19-
  长期待摊费用摊销383,186.1-705,773.71-
  处置固定资产、无形资产和其他长期资产的损失119,593.88--12,214,552.49-
  固定资产报废损失932,765.31--117,992.17-
  公允价值变动损失-3,132,844.98--2,949,322.7-
  财务费用27,550,198.48-26,492,015.63-
  投资损失1,494,351-8,145,643.14-
  递延所得税-4,808,005.68--6,967,616.7-
  其中:递延所得税资产减少-4,808,005.68--6,967,616.7-
    递延所得税负债增加0---
  存货的减少-9,986,270.43--16,720,289.81-
  经营性应收项目的减少-11,342,922.12--20,548,794.3-
  经营性应付项目的增加-3,470,697.51-39,277,628.28-
  其他-4,884,067.97--3,918,956.11-
  现金的期末余额352,018,517.59-335,982,200.74-
  减:现金的期初余额335,982,200.74-257,131,959.42-
  现金及现金等价物的净增加额16,036,316.85-78,850,241.32-
公告日期2026-08-282026-04-272026-04-272025-10-28
审计意见(境内)标准无保留意见
TOP↑